Health insurers bleed despite premium hikes
ADVERTISEMENT With a 10% cap on premium hikes for senior citizens and inflation at 14%, there is already a 4% gap, said Girija Subramanian, CMD, New India Assurance. Even after rate hikes, loss ratios have not improved and issue lies with service provider ecosystem, not underwriting, she told investors.
ICICI Lombard reported a rise in the loss ratio in its retail health book from 72.5% to 74.3% in Q1. The insurer called it a Q1 phenomenon and expects to end the year in the loss ratio range of 65-70%. "There has been an increase in incidence," said Gopal Balachandran, CFO, ICICI Lombard.
"But even when we started the last year, the Q1 number was 72.5%...ended the year at 67.9%." Star Health's incurred claims ratio climbed to 68.5% from 66.9%, while its overall loss ratio worsened to 69.5% from 68.1%. The health segment continues to dominate general insurance, accounting for 40.2% of industry gross premium income.
"There is a catch as medical inflation is not uniform across the board," said Avinash Singh, senior research analyst, Emkay Global. "Each insurer faces a different inflation curve depending on its portfolio mix. PSUs, for example, have older policyholder cohorts in their retail book who require more tertiary care and this pushes their inflation-linked claims much higher than industry averages." Niva Bupa has seen loss ratio move up to 68% on retail book. "Broadly, our loss ratio has increased by around 300 basis points," said Krishnan Ramachandran, MD, Niva Bupa. "Key drivers are a shift in business mix-group health or B2B loss ratios are structurally higher than retail-and some uptick in retail losses."
(You can now subscribe to our ETMarkets WhatsApp channel)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India.com
29 minutes ago
- India.com
Why Noted American Economist Said U.S. Wants A ‘Weaker' India; How His Prediction On Trump And Trade Deal Is Now Coming True
Washington/New Delhi: Sharing his views on India-U.S. trade relations, American economist Jeffrey Sachs expressed strong doubts about the possibility of a successful deal between the two countries. He said he would be very surprised if India managed to secure any trade deal with the United States because the U.S. government had no real interest in India's progress and aimed to keep the country weak. 'If India manages to strike a deal with the United States, I would be extremely surprised. This government (President Donald Trump's) does not care about India's well-being,' he told journalist Shweta Punj at the 'Rising Bharat Summit' hosted by Moneycontrol in April this year. Four months later, in August, the United States imposed a 25 percent tariff on Indian goods. The relationship between Washington and New Delhi has slid into a phase few predicted, but Sachs saw it coming. Once dismissed by some as exaggerated, his warning now feels eerily close to today's headlines. Trump's administration has made no secret of its stance, sanctions, public remarks criticising India's oil trade with Russia and repeated pressure over the India-Pakistan standoff. These moves, according to experts, chip away at India's autonomy and challenge the framework of sovereign diplomacy. India was among the few countries to engage early with Trump's White House for a trade agreement. The talks dragged on and nothing concrete emerged. The gap widened. Sachs tried to explain why, not with jargon but blunt words. 'America wants to use India against China. But make no mistake, this government has no interest in a stronger India,' he said. He asked people to trust what he had seen up close. 'Donald Trump is not going to open American doors to Indian manufacturers. This is a game and a strategic design to replace China, yes. But not with India,' he said. He called India a successful economy, not once but thrice. 'Very, very, very successful,' he said. He spoke of a future where India grows even stronger. In that future, Sachs said, America will not like what it sees, just as it does not like China now. Even if India opens its agriculture sector to U.S. companies, he said, the result would be the same. 'Trump will never let Indian goods flood the U.S. market. His whole idea is to block low-cost manufacturers. He is not going to let India replace China,' he said. Sachs did not stop at trade. He pointed to the larger structure, which is the global supply chain. 'They want India to help crush China. But they do not want India inside the system either. Not now. Not ever,' he added. He urged India to keep its options open. 'Never close the door to China or Russia because America's game is to prevent the rise of a strong India,' he said. Now, in August, his words feel less like a theory and more like a lived truth.
&w=3840&q=100)
Business Standard
29 minutes ago
- Business Standard
25% Donald Trump tariff likely to weigh on pharma margins: Analysts
The impact on innovator contract research, development and manufacturing organisations (CRDMOs) would be relatively lower Sohini Das Mumbai Listen to This Article If pharmaceutical exports from India to the US come under a 25 per cent tariff bracket, the impact on earnings before interest, tax, depreciation and amortisation (Ebitda) could be around 5 per cent, felt analysts. This is after assuming that about 75 per cent of the tariff would be passed on. Kotak Institutional Equities said that assuming a 25 per cent tariff on Indian pharma firms and baking in a nil pass-through, there could be a 0-27 per cent earnings per share (EPS) impact on generic drug exporters.
Time of India
29 minutes ago
- Time of India
Tea Association of India requests DGFT for review of duty-free tea imports
Guwahati: Tea Association of India (TAI) requested the Directorate General of Foreign Trade (DGFT) for Review and Regulation of Duty-Free Tea Imports under Advance Authorization Scheme . Indian Tea Industry has been witnessing a steady growth in the quantum of tea imported to India. While in 2019 15.85 million kgs of tea where imported and in 2023 the imported tea stood at 23.65million kgs. Productivity Tool Zero to Hero in Microsoft Excel: Complete Excel guide By Metla Sudha Sekhar View Program Finance Introduction to Technical Analysis & Candlestick Theory By Dinesh Nagpal View Program Finance Financial Literacy i e Lets Crack the Billionaire Code By CA Rahul Gupta View Program Digital Marketing Digital Marketing Masterclass by Neil Patel By Neil Patel View Program Finance Technical Analysis Demystified- A Complete Guide to Trading By Kunal Patel View Program Productivity Tool Excel Essentials to Expert: Your Complete Guide By Study at home View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program TAI stated that the actual export of Tea of Kenya to India in 2024 (as published by Tea Board Kenya) is huge which is 17.13 MKgs vis-à-vis 5.26 MKgs of tea in 2023 which is 226% ahead of last year and in 2025 Kenya exports tea to India till March is 3.9 MKgs which is 117% higher than 2024 for the same corresponding year. TAI added that to establish an equilibrium with regard to Supply and Demand situation, Tea Board issued the direction to curtail production, November 30, 2024. The industry also passed through adverse inclement weather conditions till the month of August, leading to a drop in production by about 110 mkgs. in the year 2024. Despite the resulting drop in production as stated above, it was noted that post September 2024 a surge in import led to poor market sentiments leading to a drop in prices by an average of Rs.60, thus adversely affecting the tea market sentiments , neutralizing the entire effort made by the Tea Board and industry to bring an equilibrium between demand and supply for the stability of the prices in tea market.
